The surveillance, epidemiology, and end results program: a national resource.
PubMedPublished 1 December 1999
Benjamin F. Hankey, Lynn A. G. Ries, B. K. Edwards
Citations585
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The fight against cancer escalated in 1971 with the introduction of the National Cancer Act during the presidency of Richard M. Nixon and since that time, there have been dramatic developments in a number of research areas including prevention, screening, and treatment.
Abstract
The fight against cancer escalated in 1971 with the introduction of the National Cancer Act during the presidency of Richard M. Nixon. Since that time, there have been dramatic developments in a number of research areas including prevention, screening, and treatment that have had a major impact on
Keywords
Medicine
Statistics in MedicinePermutation tests for joinpoint regression with applications to cancer rates
6,069 Citations2000Hyune-Ju Kim, Michael P. Fay +2 more
A joinpoint regression model is applied to describe continuous changes in the recent trend and the grid-search method is used to fit the regression function with unknown joinpoints assuming constant variance and uncorrelated errors.
CancerChanging patterns in the incidence of esophageal and gastric carcinoma in the United States
2,092 Citations1998Susan S. Devesa, William J. Blot +1 more
The authors update the incidence trends through 1994 and further consider the trends by age group.
American Journal of Public HealthEvaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico.
674 Citations1998Martin Kulldorff, W F Athas +3 more
The space-time scan statistic is useful as a screening tool for evaluating which cluster alarms merit further investigation and which clusters are probably chance occurrences.
JNCI Journal of the National Cancer InstituteCancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates
659 Citations1999Benjamin F. Hankey, Eric J. Feuer +7 more
The decline in the incidence of distant stage disease holds the promise that testing for prostate-specific antigen may lead to a sustained decline in prostate cancer mortality, however, population data are complex, and it is difficult to confidently attribute relatively small changes in mortality to any one cause.
JNCI Journal of the National Cancer InstituteAnnual Report to the Nation on the Status of Cancer, 1973-1996, With a Special Section on Lung Cancer and Tobacco Smoking
589 Citations1999Phyllis A. Wingo, Lynn A. G. Ries +6 more
The declines in cancer incidence and death rates, particularly for lung cancer, are encouraging, however, unless recent upward trends in smoking among adolescents can be reversed, the lung cancer rates that are currently declining in the United States may rise again.
PubMedCancer burden in the aged: an epidemiologic and demographic overview.
560 Citations1997Rosemary Yancik
JNCI Journal of the National Cancer InstituteRisk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer
494 Citations1997L. B. Travis, Rochelle E. Curtis +16 more
Men with testicular cancer continue to be at significantly elevated risk of second malignant neoplasms for more than two decades following initial diagnosis, and patterns of excess second cancers suggest that many factors may be involved.
BiometricsEstimating Medical Costs from Incomplete Follow-Up Data
454 Citations1997D. Y. Lin, Eric J. Feuer +2 more
Extensive numerical studies show that the asymptotic approximations are adequate for practical use and the biases of the proposed estimators are small even when censoring may occur in the interiors of the intervals.
Cancer Causes & ControlPartitioning linear trends in age-adjusted rates
418 Citations2000Benjamin F. Hankey, Lynn A. G. Ries +5 more
Trends in mortality for cancers of the colon/rectum, breast, lung/bronchus, and prostate are found to be responsible for 75% of the decreasing trend in cancer mortality.
PubMedComorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study.
414 Citations1998Rosemary Yancik, Margaret N. Wesley +5 more
American Journal of RoentgenologyBreast Cancer Surveillance Consortium: a national mammography screening and outcomes database.
406 Citations1997Rachel Ballard‐Barbash, Stephen H. Taplin +15 more
Screening effectiveness in community practice today could exceed that estimated in trials because the technical and interpretative quality of mammography has improved since the trials were performed and the level of efficacy in trials may not pertain to community practice.
JNCI Journal of the National Cancer InstituteCancer Surveillance Series: Interpreting Trends in Prostate Cancer Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer Mortality
261 Citations1999Eric J. Feuer, Ray M. Merrill +1 more
The rise and fall in prostate cancer mortality observed since the introduction of PSA testing in the general population are consistent with a hypothesis that a fixed percent of the rising and falling pool of recently diagnosed patients who die of other causes may be mislabeled as dying of prostate cancer.
JNCI Journal of the National Cancer InstituteCancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer Mortality
218 Citations1999Ruth Etzioni, Jack Legler +4 more
It is unlikely that the entire decline in prostate cancer mortality can be explained by PSA testing based on current beliefs concerning lead time, and only very short lead times would produce a decline in mortality of the magnitude that has been observed.
Annals of EpidemiologyCancer and comorbidity in older patients: A descriptive profile
215 Citations1996Rosemary Yancik, Richard J. Havlik +5 more
It is shown that hypertension is the most prevalent condition and is also much more common as a current management problem rather than as history for the NIA/NCI SEER Study patients, which will determine the impact of a patient's comorbidity burden on the cancer care continuum of diagnosis, treatment, and survival.
PubMedCost of care for cancer in a health maintenance organization.
199 Citations1997Bruce Fireman, C. P. Quesenberry +6 more
The utilization and cost results reported here may be useful in assessing the cost-effectiveness of cancer prevention and control programs, in adjusting capitation rates and budgets, and in estimating the aggregate medical care costs attributable to cancer.
Medical CareTrends and Black/White Differences in Treatment for Nonmetastatic Prostate Cancer
155 Citations1998Carrie N. Klabunde, Arnold L. Potosky +2 more
Black men were less likely to undergo radical prostatectomy than were white men, but use of radiation therapy did not differ markedly by race, and for both races, use of aggressive therapy had increased with time, although this trend appears to be slowing.
Cancer Causes & ControlThe role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States
153 Citations1998Julie Legler, Eric J. Feuer +3 more
It is informative to distinguish first from later tests when assessing the effect of the diffusion of a test in a population, and this approach was useful in illuminating the role of PSA testing in a reversal of a long-term increase in prostate cancer incidence rates.
American Journal of EpidemiologyAsymptomatic Incidence and Duration of Prostate Cancer
128 Citations1998Ruth Etzioni, Raymond Cha +2 more
Estimates of the age-specific asymptomatic incidence and average preclinical duration of prostate cancer suggest that approximately 75% of prostate cancers will never become diagnosed if clinical incidence remains at levels observed in 1984-1986, prior to the introduction of prostate-specific antigen (PSA) screening in the population.
American Journal of EpidemiologyComparison of Methods for Classifying Hispanic Ethnicity in a Population-based Cancer Registry
124 Citations1999Susan L. Stewart, Karen C. Swallen +3 more
Bias was reduced when medical records and surnames were used together to classify cancer cases as Hispanic, and ethnic classification by medical record alone resulted in an underestimate of Hispanic cancer cases and incidence rates.
Journal of Clinical EpidemiologyA method for partitioning cancer mortality trends by factors associated with diagnosis: An application to female breat cancer
112 Citations1994Kenneth C. Chu, Barry A. Miller +2 more
Breast cancer incidence-based mortality measures are created and compared to mortality rates based on death certificates over a comparable time period and novel mortality measures, such as mortality rates by stage-at-diagnosis, age at diagnosis and year-of- diagnosis, are used to illustrate the value of this approach.
JNCI Journal of the National Cancer InstituteRepresentativeness of the Surveillance, Epidemiology, and End Results Program Data: Recent Trends in Cancer Mortality Rates
102 Citations1992C.M. Frey, Marilyn M. McMillen +3 more
The demonstration that data from the SEER population do occasionally yield mortality rates that differ from those for the entire U.S. population suggests that dataFrom the SEer coverage population are, in some cases, not representative of the greater U.s. population.
Journal of Clinical EpidemiologyEstimating the costs attributable to a disease with application to ovarian cancer
94 Citations1996Ruth Etzioni, Nicole Urban +1 more
Methods appropriate for handling incomplete or censored cost and survival data, incorporating discounting, and computing attributable costs are considered, including the Kaplan-Meier sample-average (KMSA) estimator, which takes into account the censored nature of the data that are typically available.
The Journal of UrologyASSESSMENT OF PATIENT PREFERENCES AMONG MEN WITH PROSTATE CANCER
86 Citations1998Peter C. Albertsen, Robert F. Nease +1 more
A self-administered paper based instrument can be used to assess patient utilities for health states associated with prostate cancer management and results appear to be reliable and valid, and are comparable to those obtained from other assessment techniques.
Lifetime Data AnalysisEstimating Lifetime and Age-Conditional Probabilities of Developing Cancer
80 Citations1998Lap‐Ming Wun, Ray M. Merrill +1 more
A detailed description of the methodology for deriving lifetime and age-conditional risk estimates of developing cancer is presented and an extension is made which, using a triple decrement life table, adjusts for a surgical procedure that removes individuals from the risk of developing a given cancer.
Controlled Clinical TrialsUse of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening
74 Citations1997Nicole Urban, Charles W. Drescher +2 more
A multimodal strategy involving CA 125 with a threshold for positivity of either elevation above 35 U/ml or doubling since the previous screen, followed by TVS only if CA 125 is positive, was found to be efficient in the sense that no other strategies saved as many years of life at lower cost per year of life saved.
Annals of EpidemiologyPredictors of misclassification of hispanic ethnicity in a population-based cancer registry
74 Citations1997Karen C. Swallen, Dee W. West +3 more
Determinants of ethnic misclassification in a sample of 1154 cancer cases in the San Francisco-Oakland cancer registry were explored, finding those most likely to self-identify as non-Hispanic did not speak Spanish, had non-Spanish surnames, and were recent immigrants.
PubMedIs microstaging of early invasive cancer of the urinary bladder possible or useful?
71 Citations1996C. E. Platz, Michael B. Cohen +3 more
The findings suggest that microstaging of early invasive bladder cancer is technically difficult and, at least in cases derived from various urologists and laboratories, does not yield a prognostically significant separation.
CancerThe New Mexico Mammography Project: Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993
68 Citations1996Robert Rosenberg, James Lando +6 more
This project was designed to collect and link population‐based mammography and breast carcinoma data to assess the performance of community mammography screening.
Journal of Clinical OncologyRisk-based recommendations for mammographic screening for women in their forties.
66 Citations1998Mitchell H. Gail, Barbara K. Rimer
Risk-based recommendations for mammographic screening for women in their 40s that take into account the woman's age, race, and specific risk factors are developed and can be used to facilitate the counseling process.
BiometricsAdjustment of Cancer Incidence Rates for Ethnic Misclassification
39 Citations1998Susan L. Stewart, Karen C. Swallen +3 more
An ethnicity survey of cancer patients and estimating the proportion misclassified using double sampling models suggest that the number of cancer cases reported as Hispanic is an underestimate of thenumber of cases self-identified as Hispanic, resulting in an underestimated of Hispanic cancer rates.
The ProstateAge-specific prostate-specific antigen: A reassessment
27 Citations1996Ruth Etzioni, Yu Shen +2 more
The objective was to compare expected survival benefits when screening for prostate cancer with PSA, using an age‐specific bound relative to a cutoff of 4.0 ng/ml.
Statistics in MedicineESTIMATING ASYMPTOMATIC DURATION IN CANCER: THE AIDS CONNECTION
17 Citations1997Ruth Etzioni, Yu Shen
By adapting AIDS methodology to cancer, the article identifies a non-parametric method for estimating the duration of the asymptomatic period in cancer and develops an EM algorithm that, at convergence, yields a maximum or saddle point of the likelihood.
Medical Decision MakingOptimizing Sampling Strategies for Estimating Quality-adjusted Life Years
12 Citations1997Scott D. Ramsey, Ruth Etzioni +2 more
A method to optimize sampling strategies for estimating quality-adjusted life years by addressing the questions of when to sample and how many observations to sample at each sampling time, assuming realistically that the sample variance of quality of life is not constant over time.
PubMedEstimating breast cancer treatment charges in Connecticut.
7 Citations1996Anthony P. Polednak, I P Shevchenko +1 more
Data from the statewide population-based Connecticut Tumor Registry and hospital-discharge database were linked, to estimate charges for inpatient and ambulatory surgery care, finding that total hospital-related charges for comorbid conditions (during 1991-93) were considerable by age 45 to 64 years.
Urologic Oncology Seminars and Original InvestigationsProstate cancer and computer models: Background, limitations, and potential
4 Citations1996Ruth Etzioni, Ian M. Thompson
It is found that all models of localized prostate cancer decision making suffer from a number of problems, most notably due to a previously noted lack of unbiased data concerning the natural history of the disease but also due to flaws in the design of the models and the use of available data.